MikroScore
Science-backed ingredient evidence
Moderate Evidence Safety: Likely safe Study dose: 300 mg/day

Bacopa monnieri

Also known as: Bacopa monnieri, Brahmi, Water Hyssop

Summary Moderate Evidence

Bacopa is among the more credible herbal nootropics with decent data for memory, though effects remain moderate rather than dramatic.

EU Health Claims: No approved claims

The EFSA has not approved any health claims for Bacopa regarding memory, learning, or focus.

AI Summary

Quick verdict

Bacopa is among the more credible herbal nootropics with decent data for memory, though effects remain moderate rather than dramatic.

What the evidence supports

Bacopa is studied for memory, attention, and stress in multiple human trials. Evidence is notably stronger than many plant-derived nootropics, but effects remain moderate and depend on extract, dose, and duration.

What is NOT supported

Long-term safety and rare adverse effects in humans remain insufficiently studied.

EU/EFSA status

Not approved. The EFSA has not approved any health claims for Bacopa regarding memory, learning, or focus.

Safety

Likely safe

This AI summary is generated from the structured data on this page.

What is Bacopa?

Bacopa monnieri, known as brahmi in Ayurvedic medicine and water hyssop in English, is a small creeping plant native to Indian wetlands. It has been used for centuries in traditional medicine for memory and cognition; in modern supplement markets, it is one of the more evidence-backed herbal nootropics available.

The active compounds are bacosides (A and B), triterpene glycosides that appear to support synaptic plasticity and neuronal signaling.

Mechanism

Proposed mechanisms from research:

  • Antioxidant and neuroprotective: Bacopa extracts reduce oxidative stress markers in neurons and protect against excitotoxicity.
  • Synaptic plasticity: Bacopa appears to enhance dendritic and synaptic development in cell and animal studies, possibly through neurotrophic signaling.
  • Acetylcholinesterase inhibition: Weak AChE inhibition may modestly elevate acetylcholine; this is secondary to the primary mechanisms.
  • Stress buffer: Traditional use for stress and anxiety has some modern support via HPA axis modulation in animal studies.

What do human studies show?

Positive evidence

  • Multiple RCTs in healthy adults (age 18–60) report modest improvements in working memory, memory consolidation, and information processing speed over 8–12 weeks at 300 mg/day of standardized extract.
  • Stough et al. (2001) is the landmark study: in healthy volunteers, Bacopa improved memory acquisition, retention, and ease of learning relative to placebo.
  • Meta-analyses (Kongkeaw 2014) confirm small to moderate pooled benefits, particularly for memory retention.
  • Bacopa is well-tolerated; dropout rates in trials are low.

Limitations

  • Effect sizes are modest (standardized mean differences typically 0.3–0.6), corresponding to ~5–15% improvements in cognitive tests—real but not dramatic.
  • Most trials are 8–12 weeks long; longer-term (6+ month) efficacy is unclear.
  • Variability in extract standardization and bacoside content across products is high; not all “Bacopa” supplements are equivalent.
  • Publication bias is likely; small, negative studies may not be published.

Bottom line: Bacopa is genuinely one of the better-evidenced herbal nootropics. Effects are modest, but real—and replicable in independent cohorts.

Dosage in trials

  • Standard dose: 300 mg/day of standardized extract (typically 55% bacoside content).
  • Some studies use 150–600 mg/day; dose-response relationships are not clearly established.
  • Effects typically emerge over 4–8 weeks of consistent use.

Safety profile

Bacopa is well-tolerated:

  • Mild GI effects (nausea, decreased appetite) occasionally reported, usually mild and transient.
  • No toxicity or organ damage reported even at higher doses.
  • Long-term safety data (>12 months) are limited but reassuring based on traditional use.

EFSA regulatory status

  • No approved EFSA health claims for Bacopa.
  • Marketing claims about “memory support” or “cognitive enhancement” are not evidence-based per EU standards, though claims are widespread.

Comparison to other nootropics

  • vs. Alpha-GPC: Bacopa has stronger human evidence for cognition; Alpha-GPC is more specific to acetylcholine.
  • vs. L-Theanine: L-Theanine has better short-term acute effects (30–60 min); Bacopa is a chronic, slower-building agent.
  • vs. Ginkgo biloba: Comparable evidence quality; both are moderate-tier herbal nootropics.

Bottom line

Bacopa monnieri is a solid mid-to-high-tier herbal nootropic with better evidence than most plant-derived supplements. If you’re seeking modest, real memory and cognitive improvements through supplementation, Bacopa is worth trying. However, manage expectations: it is not a cognitive enhancement shortcut. Prioritize sleep, exercise, stress management, and cognitive engagement—these have far stronger evidence for brain health—before (or alongside) Bacopa. If you do experiment, aim for 300 mg/day of standardized extract (50–55% bacoside) for at least 8 weeks to assess personal response.

Key Studies

The chronic effects of Bacopa monnieri on cognitive function in healthy human subjects

Stough C et al. (2001)

One of the landmark human studies suggesting memory improvements in healthy subjects after 12 weeks of chronic Bacopa use."

PubMed PMID 11498727

Bacosides from Bacopa monnieri extract: An overview of the effects on neurological disorders

Banerjee et al. (2021)

Review: Among herbal nootropics, Bacopa has a comparatively solid human evidence base."

PubMed PMID 34254371

Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract

Kongkeaw et al. (2014)

Meta-analysis: Small to moderate cognitive benefits, but not transformative effects."

PubMed PMID 24252493
Editorial notice: For most ingredients described here, no health claims are approved in the EU (Regulation (EC) 1924/2006). Evidence levels are editorial assessments of research quality — not health promises. This content is not a substitute for medical advice and does not constitute a recommendation to treat, alleviate, or prevent any disease.